Patient-level dataset to study the effect of COVID-19 in people with Multiple Sclerosis 1.0.0

File: (226,488 bytes)

secret_name	report_source	age_in_cat	bmi_in_cat2	covid19_admission_hospital	covid19_confirmed_case	covid19_diagnosis	covid19_has_symptoms	covid19_icu_stay	covid19_outcome_recovered	covid19_self_isolation	covid19_sympt_chills	covid19_sympt_dry_cough	covid19_sympt_fatigue	covid19_sympt_fever	covid19_sympt_loss_smell_taste	covid19_sympt_nasal_congestion	covid19_sympt_pain	covid19_sympt_pneumonia	covid19_sympt_shortness_breath	covid19_sympt_sore_throat	covid19_ventilation	current_dmt	dmt_glucocorticoid	edss_in_cat2	has_comorbidities	pregnancy	sex	year_onset	ms_type2	current_or_former_smoker	dmt_type_overall	covid19_outcome_levels_2	duration_treatment_cat2	com_cardiovascular_disease	has_comorbidities.1	has_comorbidities.2	com_chronic_kidney_disease	com_chronic_liver_disease	com_diabetes	com_hypertension	com_immunodeficiency	com_lung_disease	com_malignancy	com_neurological_neuromuscular	stop_or_end_date_combined	comorbidities_other
C_1005	clinicians	1		no	yes	confirmed		no	yes	yes											no	yes		0.0	no		female		relapsing_remitting		currently on fingolimod	0			no	no
C_1008	clinicians	1		no	yes	confirmed	yes	no	yes	yes				yes							no	yes		0.0	yes		female		relapsing_remitting		currently on natalizumab	0			yes	yes						yes
C_1037	clinicians	1		no	yes	confirmed	yes	no	not_applicable	yes											no	yes		0.0	no		female		relapsing_remitting		currently on fingolimod	0			no	no
C_1039	clinicians	1		no	no	suspected	yes	no	not_applicable	yes											no	yes		0.0	no		female		relapsing_remitting		currently on another drug not listed	0			no	no
C_1061	clinicians	1		yes	no	suspected	yes	no	yes	yes	no	yes	no	yes	no	no	no	yes	no	no	no	yes	no	0.0	yes	no	female	2007.0	relapsing_remitting		currently on another drug not listed	1	1.0	no	yes	yes	no	no	no	yes	no	no	no	no	24/04/2020
C_1066	clinicians	1		yes	yes	confirmed			yes	yes												yes		0.0	yes		female		relapsing_remitting		currently on glatiramer	1			yes	yes							yes
C_1067	clinicians	1		no	yes	confirmed		no	not_applicable	yes											no	yes		0.0	no		female		relapsing_remitting		currently on fingolimod	0			no	no
C_1069	clinicians	1		no	no	suspected		no	not_applicable	yes											no	yes		0.0	yes		female		relapsing_remitting		currently on fingolimod	0			yes	yes								yes
C_1076	clinicians	1		no	no	suspected	yes	no	yes	yes						yes					no	yes		0.0	yes		female		relapsing_remitting		currently on ocrelizumab	0			yes	yes						yes			12/11/2019
C_1077	clinicians	1		no	no	suspected	yes	no	yes	yes				yes	yes	yes					no	yes		0.0	yes		female		relapsing_remitting		currently on ocrelizumab	0	1.0		yes	yes									19/09/2019	1.0
C_1079	clinicians	1		no	no	suspected	yes	no	yes	yes		yes				yes					no	yes		0.0	yes		female		relapsing_remitting		currently on ocrelizumab	0			yes	yes									18/09/2019	1.0
C_1080	clinicians	1		yes	yes	confirmed		no	yes	yes												never_treated		0.0	no		female		progressive_MS			1			no	no
C_1084	clinicians	1		no	yes	confirmed	yes	no	yes	yes		yes		yes			yes				no	yes		0.0	no		female		relapsing_remitting		currently on teriflunomide	0			no	no
C_1085	clinicians	1		no	yes	confirmed	yes	no	not_applicable	yes				yes		yes			no	yes	no	yes		0.0	no		female		relapsing_remitting		currently on dimethyl fumarate	0			no	no
C_1090	clinicians	1		no	no	suspected	yes	no	yes	yes		yes		no		yes	yes		yes	yes	no	yes		0.0	no		female		relapsing_remitting		currently on dimethyl fumarate	0			no	no
C_1096	clinicians	1		no	no	suspected	yes	no	yes	yes											no	yes		0.0	no		female		relapsing_remitting		currently on dimethyl fumarate	0			no	no
C_1097	clinicians	1		no	no	suspected	yes	no	yes	yes											no	yes		0.0	no		female		relapsing_remitting		currently on alemtuzumab	0			no	no
C_1098	clinicians	1		no	no	suspected	yes	no	yes	yes											no	yes		0.0	no		female		relapsing_remitting		currently on interferon	0			no	no
C_1103	clinicians	1		yes	yes	confirmed	yes	yes	no	yes											yes	yes		0.0	yes		female		relapsing_remitting		currently on ocrelizumab	2			yes	yes									16/02/2020	1.0
C_1106	clinicians	1		no	no	suspected	yes	no	yes	yes				yes							no	yes		0.0	no		female	2019.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no
C_1108	clinicians	1		no	no	suspected	yes	no	yes	yes											no	yes		0.0	no		female		relapsing_remitting		currently on glatiramer	0			no	no
C_1109	clinicians	1		no	no	suspected	yes	no	yes	yes											no	yes		0.0	no		female		relapsing_remitting		currently on teriflunomide	0			no	no
C_1112	clinicians	1		no	no	suspected	yes	no	not_applicable	yes		yes									no	yes		0.0	no		female		relapsing_remitting		currently on fingolimod	0			no	no
C_1114	clinicians	1		no	yes	confirmed	yes	no	not_applicable	yes		yes		yes					yes	yes	no	yes		0.0	yes		female		relapsing_remitting		currently on dimethyl fumarate	0	0.0		yes	yes						yes
C_1115	clinicians	1		no	no	suspected	yes	no	not_applicable	yes		yes		no	yes	yes			no		no	yes		0.0	no		female		relapsing_remitting		currently on ocrelizumab	0	1.0		no	no									28/11/2019
C_1117	clinicians	1		no	yes	confirmed	yes	no	yes	yes											no	yes		0.0	no		female	2019.0	relapsing_remitting		currently on natalizumab	0			no	no									16/03/2020
C_1194	clinicians	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2016.0	relapsing_remitting		currently on teriflunomide	0		no	yes	yes	no	no	no	yes	no	no	no	no	03/05/2020	1.0
C_1245	clinicians	1		no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	yes	no	female	2012.0	relapsing_remitting	yes		0		no	yes	yes	no	no	no	no	no	yes	no	no
C_1344	clinicians	1		no	no	suspected	yes	no	yes	yes		yes		yes		yes	yes				no	yes		0.0	yes	no	female		relapsing_remitting		currently on fingolimod	0		no	yes	yes	no	no		no	no	no	no	no		1.0
C_1345	clinicians	1		no	no	suspected	yes	no	yes	yes											no	yes		0.0	no		female		relapsing_remitting		currently on fingolimod	0			no	no
C_1346	clinicians	1		yes	yes	confirmed	yes	no	yes	yes												yes		0.0	yes		female		relapsing_remitting		currently on interferon	1			yes	yes						yes
C_1348	clinicians	1		no	yes	confirmed	yes	no	yes	yes											no	yes		0.0	no		female		relapsing_remitting		currently on natalizumab	0			no	no
C_1361	clinicians	1		no	yes	confirmed	yes	no	yes			yes		yes				no		yes	no	yes	no	0.0	yes	no	female		relapsing_remitting		currently on fingolimod	0		no	yes	yes	no	no	no	no	no	yes	no	no	13/03/2020
C_1364	clinicians	1		no	yes	confirmed	yes	no	yes	yes		yes	yes	yes	yes		yes	no	no	yes	no	yes	no	0.0	no	no	female		relapsing_remitting		currently on ocrelizumab	0			no	no									23/01/2020
C_341	clinicians	1		yes	yes	confirmed	yes	no	yes	yes	no	yes	yes	yes		no	no	yes	no	yes	no	yes	no	0.0	no	no	female	2017.0	relapsing_remitting		currently on fingolimod	1	1.0		no	no									07/03/2020
C_781	clinicians	1		no	no	suspected	yes	no	yes	yes	yes	yes	no	no	no	yes	no	no	no	no	no	yes		0.0	no	no	female	2001.0	relapsing_remitting		currently on ocrelizumab	0	1.0		no	no
C_783	clinicians	1		no	no	suspected	yes	no	yes	yes	yes	yes	yes	no	no	no	yes	no	yes	no	no	yes	no	0.0	no	no	female	2008.0	relapsing_remitting		currently on fingolimod	0	1.0		no	no
C_787	clinicians	1		no	no	suspected	yes	no	yes	yes	yes	yes	yes	no	no	yes	no	no	yes	no	no	yes	no	0.0	no	no	female	2005.0	relapsing_remitting		currently on cladribine	0	0.0		no	no									19/01/2020
C_788	clinicians	1		no	no	suspected	yes	no	yes	yes	yes	no	yes	yes	no	no	yes	no	no	no	no	yes	no	0.0	no	no	female	2008.0	relapsing_remitting	yes	currently on cladribine	0	0.0		no	no									08/02/2020
C_884	clinicians	1		no	no	suspected	yes	no	yes	yes	no	no	yes	no	no	no	yes	no	yes	no	no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting		currently on natalizumab	0	0.0		no	no									03/03/2020
C_885	clinicians	1		no	no	suspected	yes	no	yes	yes	no	yes	yes	no	no	yes	yes	no	no	no	no	yes	no	0.0	no	no	female	2007.0	relapsing_remitting		currently on natalizumab	0	1.0		no	no									23/02/2020
C_917	clinicians	1		no	yes	confirmed	yes	no	no	yes	no	yes	yes	yes	no	no	yes	no	yes	yes	no	yes	no	0.0	no	no	female	2012.0	relapsing_remitting		currently on fingolimod	0	1.0		no	no									10/04/2020
P_108	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	yes	0.0	no	no	female	2018.0	relapsing_remitting		currently on interferon	0			no	no									12/04/2020
P_111	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2005.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no
P_1151	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2018.0	relapsing_remitting		currently on teriflunomide	0			yes	yes									22/05/2020	1.0
P_1152	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female		relapsing_remitting	yes	currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	yes	no	yes	22/02/2020
P_1188	patients	1		no	no	suspected	yes	no	yes	yes	yes	no	yes	yes	yes	yes	yes	no	no	no	no	yes	no	0.0	no	no	female	2002.0	relapsing_remitting		currently on another drug not listed	0	1.0		no	no									13/05/2020
P_12	patients	1		no	no	suspected	yes	no	not_applicable	yes	yes	no	yes	yes	no	no	yes	no	yes	no	no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting		currently on another drug not listed	0			no	no									17/02/2020
P_1243	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									23/05/2020
P_1310	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2014.0	other		currently on another drug not listed	0			no	no									29/06/2020
P_1330	patients	1		no	no	not_suspected	yes	no	not_applicable	no						yes				yes	no	yes	no	0.0	no	no	female	2008.0	relapsing_remitting		currently on fingolimod	0			no	no									28/06/2020
P_1333	patients	1		no	no	suspected	yes	no	not_applicable	yes		yes	yes				yes			yes	no	never_treated	no	0.0	no	no	female	2016.0	relapsing_remitting	yes		0			no	no
P_163	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2016.0	other	yes	currently on fingolimod	0		no	yes	yes	no	no	no	no	no	yes	no	no
P_165	patients	1		no	no	not_suspected	yes	no	not_applicable	no	yes	no	no	no	no	yes	no	no	no	yes	no	yes	no	0.0	yes	no	female	2000.0	relapsing_remitting	yes	currently on interferon	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	26/03/2020	1.0
P_189	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2001.0	relapsing_remitting		currently on interferon	0		no	yes	yes	no	no	no	no	yes	no	no	no	21/03/2020	1.0
P_236	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2013.0	relapsing_remitting	yes	currently on cladribine	0		no	yes	yes	no	no	no	no	no	no	no	no	22/04/2019	1.0
P_249	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2017.0	relapsing_remitting		currently on interferon	0			no	no									16/03/2020
P_319	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting		currently on interferon	0			no	no									11/04/2020
P_330	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2017.0	relapsing_remitting		currently on natalizumab	0			no	no									25/03/2020
P_342	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2009.0	relapsing_remitting		currently on rituximab	0		no	yes	yes	no	no	no	no	no	no	no	no	17/01/2020	1.0
P_349	patients	1		no	no	not_suspected	no	no	no	no											no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on cladribine	0			no	no									30/12/2018
P_395	patients	1		no	no	suspected	yes	no	not_applicable	yes	yes	yes	yes	no	no	yes	yes	no	yes	yes	no	no	no	0.0	yes	no	female	1991.0	relapsing_remitting	yes	currently not using any DMT	0		no	yes	yes	no	no	no	no	no	yes	no	no	12/05/2018
P_429	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	no	no	0.0	no	yes	female	2004.0	relapsing_remitting		currently not using any DMT	0			no	no									28/01/2020
P_439	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2013.0	relapsing_remitting	yes	currently on ocrelizumab	0		no	yes	yes	no	no	no	no	no	no	no	no	28/01/2020	1.0
P_455	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2005.0	relapsing_remitting	yes	currently on interferon	0		no	yes	yes	no	no	no	no	no	yes	no	no	22/03/2020
P_496	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2015.0	progressive_MS	yes	currently on another drug not listed	0			no	no									26/03/2020
P_517	patients	1		no	no	not_suspected	yes	no	not_applicable	no	yes	no	yes	no	no	yes	yes	no	no	no	no	yes	no	0.0	yes	no	female	2008.0	relapsing_remitting		currently on another drug not listed	0	1.0	no	yes	yes	no	no	no	no	no	no	no	yes	26/03/2020	1.0
P_518	patients	1		no	no	not_suspected	no	no	no	no											no	yes	no	0.0	yes	no	female	2017.0	progressive_MS	yes	currently on natalizumab	0			yes	yes					yes				18/03/2020
P_532	patients	1		no	no	not_suspected	no	no	no	no											no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting		currently on another drug not listed	0			no	no									21/04/2018
P_548	patients	1		no	no	suspected	yes	no	not_applicable	yes	yes	yes	yes	yes	yes	yes	yes	no	yes	yes	no	never_treated	no	0.0	no	no	female	2018.0	relapsing_remitting	yes		0			no	no
P_55	patients	1		no	no	not_suspected	no	no	no	no											no	never_treated	no	0.0	no	no	female	2019.0	relapsing_remitting	yes		0			no	no
P_562	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2008.0	relapsing_remitting		currently on another drug not listed	0			no	no									08/04/2020
P_577	patients	1		no	no	not_suspected	yes	no	not_applicable	no	yes	no	no	no	no	yes	no	no	yes	no	no	no	no	0.0	yes	no	female	2005.0	other		currently not using any DMT	0	0.0	no	yes	yes	no	no	no	no	no	no	no	no	17/09/2017	1.0
P_600	patients	1		no	no	suspected	yes	no	not_applicable	yes	yes	no	yes	yes	no	yes	no	no	no	yes	no	yes	no	0.0	yes	no	female	2016.0	relapsing_remitting		currently on glatiramer	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	01/04/2020	1.0
P_793	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2004.0	relapsing_remitting		currently on glatiramer	0		no	yes	yes	no	no	no	no	no	no	no	no	06/04/2020	1.0
P_794	patients	1		no	no	suspected	yes	no	not_applicable	yes	yes	yes	yes	yes	no	yes	yes	no	no	yes	no	yes	no	0.0	yes	no	female	2015.0	other	yes	currently on another drug not listed	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	03/04/2020	1.0
P_804	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2002.0	relapsing_remitting		currently on dimethyl fumarate	0		no	yes	yes	no	no	no	no	no	no	no	no	07/04/2020	1.0
P_902	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2019.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			yes	yes									24/04/2020	1.0
P_908	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2008.0	other		currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	23/04/2020	1.0
P_93	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2003.0	other		currently on another drug not listed	0			no	no									31/12/2019
P_932	patients	1		no	yes	confirmed	yes	no	yes	yes		yes		no			yes			yes	no	never_treated	no	0.0	yes	no	female	2006.0	relapsing_remitting			0		no	yes	yes	no	no	no	no	no	no	no	no		1.0
P_957	patients	1		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2020.0	progressive_MS		currently on another drug not listed	0			no	no									07/04/2020
P_973	patients	1		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2011.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									28/04/2020
P_986	patients	1		no	no	suspected	yes	no	yes	no	no	yes	no	no	yes	yes	no	no	no	no	no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no
C_1006	clinicians	2		no	yes	confirmed		no	yes	yes											no	yes		0.0	no		female		relapsing_remitting		currently on dimethyl fumarate	0			no	no
C_1070	clinicians	2		yes	yes	confirmed	yes	yes	not_applicable	yes		yes		yes					yes			yes		0.0	no		female		relapsing_remitting		currently on ocrelizumab	2	1.0		no	no									30/10/2019
C_1071	clinicians	2		no	no	suspected	yes	no	not_applicable	yes				yes					yes	yes	no	yes		0.0	yes		female		relapsing_remitting		currently on natalizumab	0			yes	yes									13/03/2020	1.0
C_1074	clinicians	2		no	no	suspected	yes	no	not_applicable	yes		yes					yes				no	yes		0.0	no		female		relapsing_remitting		currently on dimethyl fumarate	0			no	no
C_1075	clinicians	2		no	no	suspected	yes	no	not_applicable	yes				no		yes					no	yes		0.0	yes		female		relapsing_remitting		currently on ocrelizumab	0			yes	yes			yes						09/03/2020
C_1078	clinicians	2		yes	yes	confirmed			no	yes												yes		0.0	no		female		relapsing_remitting		currently on dimethyl fumarate	1			no	no
C_1089	clinicians	2		no	no	suspected		no	not_applicable	yes											no	yes		0.0	yes		female		relapsing_remitting		currently on natalizumab	0			yes	yes									04/03/2020	1.0
C_1104	clinicians	2		no	no	suspected	yes	no	yes	yes	no			yes		yes				yes	no	yes		0.0	no		female		relapsing_remitting		currently on ocrelizumab	0	1.0		no	no									03/03/2020
C_1363	clinicians	2		no	yes	confirmed	yes	no	yes	yes		yes	yes	yes				no	no	yes	no	yes	no	0.0	yes	no	female		relapsing_remitting		currently on fingolimod	0		no	yes	yes	no	no	no	yes	no	no	no	no	05/04/2020
C_782	clinicians	2		no	no	suspected	yes	no	yes	yes	no	yes	yes	no	no	yes	no	no	no	no	no	yes	no	0.0	no	no	female	2008.0	relapsing_remitting		currently on another drug not listed	0	1.0		no	no									26/02/2020
C_789	clinicians	2		yes	yes	confirmed	yes	yes	yes	yes	yes	yes	yes	yes	no	yes	no	no	yes	no	yes	yes	no	0.0	yes	no	female	2000.0	relapsing_remitting	yes	currently on another drug not listed	2	1.0		yes	yes			yes	yes
C_790	clinicians	2		no	no	suspected	yes	no	yes	yes	yes	yes	yes	yes	yes	no	yes	no	yes	no	no	yes	no	0.0	no	no	female	2007.0	relapsing_remitting		currently on cladribine	0	0.0		no	no									26/01/2020
C_886	clinicians	2		no	no	suspected	yes	no	yes	yes	no	yes	yes	yes	no	no	yes	no	no	yes	no	yes	no	0.0	no	no	female	1975.0	relapsing_remitting		currently on another drug not listed	0	1.0		no	no
C_996	clinicians	2		no	yes	confirmed	yes	no	no	yes											no	yes		0.0	no		female		relapsing_remitting		currently on dimethyl fumarate	0			no	no
P_1211	patients	2		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female		progressive_MS		currently on interferon	0		no	yes	yes	no	no	no	no	no	no	no	yes	22/05/2020
P_1371	patients	2		no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2005.0	progressive_MS		currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	16/08/2020
P_141	patients	2		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2020.0	relapsing_remitting	yes	currently on teriflunomide	0			no	no									01/03/2020
P_248	patients	2		no	no	not_suspected	no	no	not_applicable												no	yes	no	0.0	yes	no	female	2010.0	relapsing_remitting		currently on interferon	0			yes	yes	no	no	no	yes	no	no	no	no	09/04/2020	1.0
P_290	patients	2		no	no	not_suspected	no	no	not_applicable	no											no	no	no	0.0	no	no	female	1996.0	progressive_MS	yes	currently not using any DMT	0			no	no
P_293	patients	2		no	no	not_suspected	yes	no	not_applicable	no	no	yes	no	no	yes	no	no	no	no	no	no	yes	no	0.0	no	no	female	2007.0	relapsing_remitting		currently on ocrelizumab	0	1.0		no	no									18/10/2019
P_464	patients	2		no	no	not_suspected	no	no	no	yes											no	yes	no	0.0	no	no	female	1989.0	progressive_MS	yes	currently on ocrelizumab	0			no	no									08/01/2020
P_472	patients	2		no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	no	no	female	1990.0	progressive_MS	yes		0			no	no
P_644	patients	2		no	no	suspected	yes	no	not_applicable	no	yes	yes	yes		no		yes	no		yes	no	yes	no	0.0	no	no	female	2000.0	other	yes	currently on teriflunomide	0	1.0		no	no									17/04/2020
P_659	patients	2		no	no	not_suspected	no	no	not_applicable	yes											no	no	no	0.0	no	no	female		relapsing_remitting		currently not using any DMT	0			no	no									20/03/2019
P_907	patients	2		no	no	suspected	yes	no	not_applicable	no	no	no	yes	no	yes	no	yes	no	no	yes	no	yes	no	0.0	no	no	female	1996.0	relapsing_remitting		currently on interferon	0	1.0		no	no									21/04/2020
P_913	patients	2		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female		relapsing_remitting		currently on another drug not listed	0		yes	yes	yes	no	no	no	no	no	yes	no	no
P_941	patients	2		no	no	not_suspected	no	no	not_applicable	yes											no	no	no	0.0	no	no	female	2005.0	relapsing_remitting	yes	currently not using any DMT	0			no	no									11/04/2016
P_944	patients	2		no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	1990.0	relapsing_remitting	yes	currently on another drug not listed	0		no	yes	yes	no	no	no	no	yes	no	no	no	27/04/2020	1.0
C_924	clinicians	2	not_overweight	yes	yes	confirmed	yes	no	yes	yes	no	yes	yes	yes	no	no	yes	yes	yes	yes	yes	yes	no	0.0	no		male	1998.0	relapsing_remitting		currently on teriflunomide	2	1.0		no	no									03/04/2020
P_1019	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no		male	2005.0	progressive_MS	yes	currently on another drug not listed	0			no	no									30/04/2020
P_1042	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	no	0.0	yes		male	2000.0	relapsing_remitting		currently not using any DMT	0		no	yes	yes	no	no	no	no	yes	no	yes	no	24/01/2019
P_1044	patients	2	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes	yes		yes		yes	yes			yes	no	never_treated	no	0.0	no		male	2004.0	progressive_MS			0			no	no
P_1131	patients	2	not_overweight	no	no	not_suspected	yes	no	not_applicable	yes										yes	no	yes	no	0.0	yes		male	2016.0	relapsing_remitting		currently on dimethyl fumarate	0	1.0		yes	yes				yes					02/05/2020
P_1237	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no		male	2020.0	progressive_MS	yes	currently on ocrelizumab	0			no	no									02/10/2019
P_1272	patients	2	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no	0.0	no		male		progressive_MS	yes	currently on ocrelizumab	0			no	no									19/10/2019
P_1289	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	no	0.0	no		male	2014.0	progressive_MS		currently not using any DMT	0			no	no									20/05/2019
P_194	patients	2	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no	0.0	no		male	1986.0	relapsing_remitting		currently on another drug not listed	0			no	no									22/03/2020
P_279	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes		male	2020.0	relapsing_remitting		currently on fingolimod	0		yes	yes	yes	no	no	no	yes	no	no	no	no	17/04/2020
P_353	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no		male	2007.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no
P_372	patients	2	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no	0.0	yes		male	1980.0	relapsing_remitting		currently on teriflunomide	0		no	yes	yes	no	no	no	no	no	no	no	no	12/04/2020	1.0
P_399	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no		male	1984.0	relapsing_remitting		currently on another drug not listed	0			no	no									17/04/2020
P_404	patients	2	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no	0.0	no		male	1986.0	relapsing_remitting		currently on another drug not listed	0			no	no									01/04/2020
P_415	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no		male	1985.0	relapsing_remitting		currently on another drug not listed	0			no	no									18/05/2018
P_432	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no		male	1996.0	progressive_MS	yes	currently on another drug not listed	0			no	no									28/02/2020
P_436	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	no	0.0	no		male	1999.0	relapsing_remitting	yes	currently not using any DMT	0			no	no									14/10/2008
P_53	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	no	no	0.0	yes		male	2003.0	other	yes	currently not using any DMT	0		no	yes	yes	no	no	no	yes	no	no	no	no	30/06/2018
P_533	patients	2	not_overweight	no	yes	confirmed	yes	no	yes	yes	no	yes	yes	yes	no	no	yes	no	no	no	no	yes	no	0.0	no		male	2002.0	relapsing_remitting	yes	currently on another drug not listed	0	1.0		no	no									13/04/2020
P_542	patients	2	not_overweight	no	no	suspected	yes	no	yes	yes	no	yes	yes	yes	yes	no	yes	no	no	yes	no	no		0.0	no		male	2010.0	progressive_MS	yes	currently not using any DMT	0	1.0		no	no									27/03/2019
P_569	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no		male	2012.0	relapsing_remitting	yes	currently on glatiramer	0			no	no									18/04/2020
P_679	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no		male	1995.0	progressive_MS	yes	currently on ocrelizumab	0			no	no									01/01/2020
P_742	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no		male	2011.0	progressive_MS	yes	currently on another drug not listed	0			no	no									08/01/2020
P_743	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	yes		male	2005.0	relapsing_remitting			0		no	yes	yes	no	no	no	no	no	yes	no	no		1.0
P_814	patients	2	not_overweight	no	no	not_suspected	yes	no	yes	no			yes							yes	no	yes	no	0.0	no		male	2015.0	relapsing_remitting		currently on another drug not listed	0	1.0		no	no									26/03/2017
P_844	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	no	0.0	no		male	2008.0	relapsing_remitting		currently not using any DMT	0			no	no									11/05/2019
P_880	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	no		male	2012.0	relapsing_remitting			0			no	no
P_969	patients	2	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no		male	2016.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									22/04/2020
C_1007	clinicians	1	not_overweight	no	yes	confirmed	yes	no	no	yes				no					yes		no	yes		0.0	no		female		relapsing_remitting		currently on dimethyl fumarate	0			no	no
C_1048	clinicians	1	not_overweight	no	yes	confirmed	yes	no	yes		yes	no	yes	no	no	yes	yes	no	no	yes	no	yes	no	0.0	no	no	female	2006.0	relapsing_remitting		currently on dimethyl fumarate	0	1.0		no	no									06/04/2020
C_1051	clinicians	1	not_overweight	no	yes	confirmed	yes	no	yes	no	no	no	yes	no	yes	no	yes	no	no	no	no	yes	no	0.0	yes	no	female	2003.0	relapsing_remitting		currently on dimethyl fumarate	0	1.0	no	yes	yes	no	no	no	no	no		no	no	08/04/2020	1.0
C_1091	clinicians	1	not_overweight	no	yes	confirmed	no	no	yes												no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on interferon	0			no	no									26/04/2020
C_1308	clinicians	1	not_overweight	no	yes	confirmed	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2019.0	relapsing_remitting		currently on dimethyl fumarate	0		no	yes	yes	no	no	no	no	no	no	no	no	27/06/2020	1.0
C_1336	clinicians	1	not_overweight	no	yes	confirmed	yes	no	no	yes	no	no	no	no	yes	no	no	no	no	no	no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting		currently on another drug not listed	0	1.0		no	no									08/07/2020
C_1372	clinicians	1	not_overweight	no	yes	confirmed	yes	no	yes		no	yes	yes	no	yes	yes	no	no	yes	yes	no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting		currently on cladribine	0	1.0		no	no									29/12/2019
C_1376	clinicians	1	not_overweight	yes	no	not_suspected	no	yes	yes	no											yes	yes	yes	0.0	yes	no	female	2020.0	relapsing_remitting	yes		2		no	yes	yes	yes	yes	no	yes	yes	no	no	yes	02/08/2020
C_1378	clinicians	1	not_overweight	no	no	not_suspected	yes	no	yes	no	no	no	yes	no	yes	yes	no	no	no	no	no	yes	yes	0.0	no	no	female	2015.0	relapsing_remitting		currently on interferon	0	0.0		no	no									15/05/2020
C_1385	clinicians	1	not_overweight	no	yes	confirmed	yes	no	yes		yes	yes	no	no	yes	no	no	no	no	no	no	yes	no	0.0	yes	no	female	2019.0	relapsing_remitting		currently on glatiramer	0	0.0	no	yes	yes	no	no	no	no	no	no	no	yes	20/09/2020	1.0
P_10	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2012.0	relapsing_remitting		currently on cladribine	0			no	no									26/01/2020
P_1000	patients	1	not_overweight	no	no	not_suspected	no	no	yes	yes											no	yes	no	0.0	no	no	female	2000.0	relapsing_remitting	yes	currently on rituximab	0			no	no									18/04/2020
P_1012	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2002.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									25/04/2020
P_1017	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2003.0	relapsing_remitting	yes	currently on natalizumab	0		no	yes	yes	no	no	no	no	no	no	no	no	04/04/2020	1.0
P_1023	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2019.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									02/05/2020
P_1026	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	never_treated	no	0.0	no	no	female	2014.0	relapsing_remitting			0			no	no
P_1029	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting		currently on another drug not listed	0			no	no									14/05/2020
P_1031	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	1998.0	relapsing_remitting		currently on natalizumab	0		no	yes	yes	no	no	no	no	no	no	no	no	11/05/2020	1.0
P_1032	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	no	0.0	yes	no	female	2014.0	relapsing_remitting	yes	currently not using any DMT	0		no	yes	yes	no	no	no	no	no	no	no	no	15/03/2019	1.0
P_1033	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2017.0	relapsing_remitting	yes	currently on teriflunomide	0			no	no									30/04/2020
P_1034	patients	1	not_overweight	no	no	suspected	yes	no	yes	no				yes			yes			yes	no	yes	no	0.0	no	no	female	2020.0	relapsing_remitting	yes	currently on teriflunomide	0	1.0		no	no									24/04/2020
P_1055	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2015.0	other		currently on fingolimod	0			no	no									07/05/2020
P_1063	patients	1	not_overweight	no	no	not_suspected	no	no	no	yes											no	yes	no	0.0	no	no	female	2009.0	relapsing_remitting		currently on ocrelizumab	0			no	no
P_1094	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2012.0	relapsing_remitting		currently on fingolimod	0		no	yes	yes	no	yes	no	no	no	no	no	no	14/05/2020	1.0
P_1128	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes		yes	yes			yes	yes			yes	no	yes	no	0.0	no	no	female	2014.0	relapsing_remitting		currently on ocrelizumab	0	1.0		no	no									13/11/2019
P_1135	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	yes	no	female	2018.0	relapsing_remitting	yes		0		no	yes	yes	no	no	no	no	no	no	no	no		1.0
P_1158	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes	no	yes	yes	no	yes	yes	no	no	no	no	yes	no	0.0	no	no	female	2004.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									09/05/2020
P_116	patients	1	not_overweight	no	no	suspected	yes	no	no	yes	no	yes	yes	yes	no	yes	no	no	yes	yes	no	yes	no	0.0	no	no	female	2000.0	relapsing_remitting	yes	currently on another drug not listed	0	1.0		no	no									16/04/2020
P_1163	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2010.0	other		currently on interferon	0		no	yes	yes	no	no	no	yes	no	yes	no	no	23/04/2020
P_1173	patients	1	not_overweight	no	no	not_suspected	yes	no	yes	no	yes	no	yes	no		yes	yes	no	no	yes	no	yes	no	0.0	yes	no	female	2013.0	relapsing_remitting		currently on dimethyl fumarate	0		no	yes	yes	no	no	no	no	no	no	no	no	23/11/2017
P_1175	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2004.0	relapsing_remitting	yes	currently on fingolimod	0			no	no									21/05/2020
P_1181	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	yes			yes				yes				no	yes	no	0.0	no	no	female	2007.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									14/05/2020
P_1185	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	no	no	female	2011.0	relapsing_remitting			0			no	no
P_1186	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no		yes	yes			yes	yes			yes	no	yes	no	0.0	no	no	female	1999.0	relapsing_remitting	yes	currently on glatiramer	0	0.0		no	no									08/12/2015
P_1187	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	no	no	0.0	no	no	female	2011.0	relapsing_remitting		currently not using any DMT	0			no	no									25/01/2019
P_1193	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes		0.0	no	no	female	2020.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									11/05/2020
P_1197	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	never_treated	no	0.0	no	no	female	2004.0	other			0			no	no
P_1198	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes		yes	yes		yes	yes				no	yes	no	0.0	yes	no	female		relapsing_remitting		currently on cladribine	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	19/09/2019	1.0
P_1204	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2002.0	relapsing_remitting		currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	13/05/2020	1.0
P_1216	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	yes	0.0	no	no	female	2003.0	relapsing_remitting	yes	currently on alemtuzumab	0			no	no									12/02/2019
P_1236	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2001.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									06/05/2020
P_1244	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on glatiramer	0			no	no									07/05/2020
P_126	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									31/03/2020
P_127	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2014.0	relapsing_remitting		currently on natalizumab	0		no	yes	yes	no	no	no	no	no	no	no	no		1.0
P_1273	patients	1	not_overweight	no	yes	confirmed	yes	no	yes	yes	no	no	yes	no	yes	yes	no	no	no	no	no	yes	no	0.0	no	no	female	2007.0	relapsing_remitting		currently on interferon	0	1.0		no	no									31/05/2020
P_1278	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting		currently on ocrelizumab	0			no	no									12/03/2020
P_1280	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	no	no	0.0	no	no	female	2011.0	relapsing_remitting		currently not using any DMT	0			no	no									21/07/2019
P_1293	patients	1	not_overweight	no	no	suspected	yes	no	yes	no	no	yes	yes	no	no	yes	no	no	no	yes	no	yes	no	0.0	yes	no	female	2009.0	relapsing_remitting		currently on another drug not listed	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	02/06/2020	1.0
P_1296	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes		yes		yes		yes			yes	yes	no	yes	no	0.0	no	no	female	2000.0	relapsing_remitting	yes	currently on another drug not listed	0	1.0		no	no									20/06/2020
P_1297	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2007.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									23/06/2020
P_1302	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no		yes	yes							yes	no	no	no	0.0	no	no	female	2020.0	progressive_MS		currently not using any DMT	0	0.0		no	no									15/04/2020
P_1305	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	yes	no	no	yes	yes	yes	yes	yes	no	yes	yes	no	no	no	0.0	yes	no	female	2000.0	relapsing_remitting	yes	currently not using any DMT	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	10/12/2006	1.0
P_1306	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	yes	no	no	yes	yes	no	no	yes	yes	no	yes	no	0.0	yes	no	female	2018.0	progressive_MS		currently on another drug not listed	0	0.0	no	yes	yes	no	no	no	no	no	no	no	no	14/06/2020	1.0
P_1311	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2004.0	relapsing_remitting		currently on ocrelizumab	0			no	no
P_1316	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female		relapsing_remitting		currently on cladribine	0			no	no									29/04/2020
P_1320	patients	1	not_overweight	no	no	suspected	yes	no	yes	no	no	yes	yes	yes	no	no	yes	no	yes	yes	no	yes	no	0.0	no	no	female	2013.0	relapsing_remitting	yes	currently on glatiramer	0	1.0		no	no									27/06/2020
P_1322	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2006.0	relapsing_remitting		currently on another drug not listed	0			yes	yes									31/07/2019	1.0
P_1325	patients	1	not_overweight	no	no	suspected	yes	no	yes	no	no	no	yes	yes	no	yes	yes	no	yes	no	no	no	no	0.0	no	no	female		relapsing_remitting	yes	currently not using any DMT	0	1.0		no	no									07/02/2020
P_1334	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	1994.0	relapsing_remitting		currently on fingolimod	0			no	no									27/06/2020
P_1339	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2013.0	relapsing_remitting		currently on natalizumab	0			no	no									24/07/2020
P_134	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2009.0	relapsing_remitting	yes	currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	11/04/2020	1.0
P_1342	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	yes	no	female	2003.0	progressive_MS			0		no	yes	yes	no	no		no	no		no	no		1.0
P_1343	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	never_treated	no	0.0	yes	no	female	1987.0	relapsing_remitting	yes		0			yes	yes										1.0
P_135	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2001.0	relapsing_remitting		currently on fingolimod	0			no	no
P_14	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2006.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									09/04/2020
P_140	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2013.0	relapsing_remitting		currently on interferon	0		yes	yes	yes	no	no	no	no	no	no	no	no	30/03/2020
P_156	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	no	no	0.0	no	no	female	2007.0	relapsing_remitting	yes	currently not using any DMT	0			no	no									11/04/2020
P_166	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2007.0	relapsing_remitting	yes	currently on glatiramer	0			no	no									19/03/2020
P_171	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	yes	no	yes	yes	yes	no	no	yes	no	yes	no	no	yes	no	0.0	yes	no	female	2010.0	relapsing_remitting		currently on fingolimod	0	1.0	no	yes	yes	no	no	no	no		no	no	no	06/04/2020	1.0
P_173	patients	1	not_overweight	no	no	suspected	yes	no	yes	no		yes	yes	yes			yes				no	yes	no	0.0	no	no	female	2012.0	relapsing_remitting	yes	currently on natalizumab	0	1.0	no	no	no	no	no	no	no					26/03/2020
P_178	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2012.0	relapsing_remitting	yes	currently on glatiramer	0			no	no									01/04/2020
P_180	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2004.0	relapsing_remitting		currently on cladribine	0			no	no									25/08/2019
P_184	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting		currently on cladribine	0			no	no									23/06/2019
P_192	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	no	0.0	no	no	female	2013.0	relapsing_remitting		currently not using any DMT	0			no	no									30/11/2018
P_193	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	never_treated	no	0.0	no	no	female	2008.0	relapsing_remitting	yes		0			no	no
P_195	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2008.0	relapsing_remitting	yes	currently on fingolimod	0			no	no									02/04/2020
P_20	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2008.0	relapsing_remitting	yes	currently on fingolimod	0		no	yes	yes	no	no	no	no	no	no	no	no	07/04/2020	1.0
P_205	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2017.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									17/04/2020
P_206	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	no	no	0.0	yes	no	female	2007.0	relapsing_remitting		currently not using any DMT	0		no	yes	yes	no	no	no	no	no	no	no	no	31/12/2019	1.0
P_209	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2017.0	relapsing_remitting		currently on fingolimod	0			no	no
P_21	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2018.0	relapsing_remitting	yes	currently on rituximab	0		no	yes	yes	no	no	no	no	yes	no	no	yes	28/11/2019	1.0
P_211	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	no	no	female	2000.0	other			0			no	no
P_22	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2013.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									04/04/2020
P_222	patients	1	not_overweight	no	no	suspected	yes	no	no	no			yes	yes			yes				no	yes	no	0.0	no	no	female	2006.0	progressive_MS	yes	currently on ocrelizumab	0	0.0		no	no
P_224	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	no	yes	yes	no	no	no	no	no	no	no	yes	no	0.0	no	no	female	2004.0	relapsing_remitting	yes	currently on interferon	0	1.0		no	no									14/04/2020
P_226	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2009.0	relapsing_remitting	yes	currently on natalizumab	0		no	no	no		no	no	no					29/03/2020
P_232	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2008.0	relapsing_remitting	yes	currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	14/03/2020	1.0
P_239	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	no	yes	yes	no	yes	yes	no	no	no	no	yes	no	0.0	no	no	female	2008.0	other	yes	currently on cladribine	0			no	no									23/03/2020
P_24	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	yes	yes	no	no	no	no	no	no	no	no	yes	no	0.0	yes	no	female	2010.0	relapsing_remitting		currently on another drug not listed	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	11/04/2020	1.0
P_241	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no	no	no	yes	no	no	yes	no	no	no	yes	no	yes	no	0.0	yes	no	female	2012.0	relapsing_remitting		currently on natalizumab	0		no	yes	yes	no	no	no	no	no	no	no	no	08/04/2020	1.0
P_258	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting		currently on natalizumab	0			no	no									27/03/2020
P_26	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes	yes	yes	yes	no	yes	yes	no	no	yes	no	yes	no	0.0	no	no	female	2004.0	relapsing_remitting		currently on natalizumab	0	1.0		no	no									28/02/2020
P_262	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2012.0	relapsing_remitting	yes	currently on interferon	0		no	yes	yes	no	no	no	no	no	no	no	no	23/03/2020	1.0
P_266	patients	1	not_overweight	no	no	suspected	yes	no	no	yes			yes	yes						yes	no	yes	no	0.0	no	no	female	2011.0	relapsing_remitting		currently on fingolimod	0	1.0		no	no									17/04/2020
P_267	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no	no	no	yes		no	yes	yes	no	no	no	no	yes	no	0.0	no	no	female	2003.0	relapsing_remitting	yes	currently on another drug not listed	0	1.0		no	no									13/04/2020
P_271	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no	no	yes	no	no	no	no	no	no	no	no	no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on another drug not listed	0	1.0		no	no									06/04/2020
P_281	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	no	yes	0.0	yes	no	female	2016.0	relapsing_remitting	yes	currently not using any DMT	0		no	yes	yes	no	no	no	no	no	no	no	no	13/01/2020	1.0
P_283	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	never_treated	no	0.0	no	no	female	2008.0	relapsing_remitting			0			no	no
P_285	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on natalizumab	0			no	no									26/03/2020
P_286	patients	1	not_overweight	no	no	suspected	yes	no	no	yes	yes	yes	yes			yes	yes			yes	no	yes	no	0.0	yes	no	female		relapsing_remitting	yes	currently on natalizumab	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	01/04/2020	1.0
P_297	patients	1	not_overweight	no	no	suspected	yes	no	no	no	no	yes	yes	no	no	no	no	no	yes	no	no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting		currently on glatiramer	0	1.0		no	no									16/04/2020
P_299	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									14/04/2020
P_302	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes	yes			yes	yes	yes	yes				no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting		currently on dimethyl fumarate	0	1.0		no	no									09/04/2020
P_311	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	yes	no	female	2003.0	progressive_MS			0			yes	yes										1.0
P_314	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2009.0	relapsing_remitting		currently on another drug not listed	0		no	yes	yes	no	no	no	no	yes	yes		no	11/03/2020
P_315	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2009.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									31/03/2020
P_316	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2014.0	relapsing_remitting		currently on glatiramer	0			no	no
P_317	patients	1	not_overweight	no	no	suspected	yes	no	no	yes		yes	yes	yes		yes	yes				no	yes	no	0.0	yes	no	female	2003.0	relapsing_remitting		currently on natalizumab	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	14/03/2020	1.0
P_318	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes	yes	yes	yes	no	no	yes	yes	no	yes	yes	no	yes	no	0.0	yes	no	female	2019.0	other		currently on dimethyl fumarate	0	0.0	no	yes	yes	no	no	no	no	no	no	no	no	06/04/2020	1.0
P_320	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	no	no	female	2019.0	relapsing_remitting			0			no	no
P_322	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2018.0	relapsing_remitting		currently on ocrelizumab	0		no	yes	yes	no	no	no	no	no	no	no	no	30/12/2019	1.0
P_325	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no	0.0	yes	no	female	2018.0	relapsing_remitting		currently on another drug not listed	0			yes	yes									30/03/2020	1.0
P_329	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									12/04/2020
P_331	patients	1	not_overweight	no	no	not_suspected	no	no	no	yes											no	yes	yes	0.0	no	no	female	2002.0	relapsing_remitting	yes	currently on fingolimod	0			no	no									29/03/2020
P_332	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2011.0	relapsing_remitting	yes	currently on glatiramer	0		no	yes	yes	no	no	no	no	no	no	no	no	17/04/2020	1.0
P_333	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting		currently on fingolimod	0			no	no									28/03/2020
P_334	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	yes	0.0	yes	no	female		other		currently on ocrelizumab	0		no	yes	yes	no	no	no	no	no	yes	no	no
P_337	patients	1	not_overweight	no	yes	confirmed	yes	no	yes	yes	yes	yes	yes	no	yes	yes	no	no	no	yes	no	yes	no	0.0	no	no	female	2019.0	relapsing_remitting	yes	currently on teriflunomide	0	1.0		no	no
P_338	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2009.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no
P_344	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2017.0	relapsing_remitting		currently on dimethyl fumarate	0		no	yes	yes	no	no	no	no	no	no	no	no	03/04/2020	1.0
P_345	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2017.0	relapsing_remitting	yes	currently on cladribine	0		no	yes	yes	yes	no	no	no	no	no	no	no	20/03/2020
P_352	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes	no	yes	yes	no	yes	yes	no	no	no	no	no	no	0.0	yes	no	female	2015.0	relapsing_remitting		currently not using any DMT	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	11/03/2019	1.0
P_354	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2017.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									09/04/2020
P_359	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2002.0	relapsing_remitting	yes	currently on ocrelizumab	0			yes	yes								yes	22/02/2020
P_364	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	yes	no	female	2008.0	relapsing_remitting	yes		0		no	yes	yes	no	no	no	yes	no	no	no	no		1.0
P_366	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2009.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									26/10/2018
P_369	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting	yes	currently on rituximab	0			no	no									07/11/2019
P_37	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	1997.0	relapsing_remitting	yes	currently on interferon	0			no	no									09/04/2020
P_370	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes	yes	yes	no	no	yes	no	no	yes		no	never_treated	no	0.0	yes	no	female	1988.0	other			0		no	yes	yes	no	no	no	no	no	no	no	no		1.0
P_378	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	yes	yes						yes		yes	yes	no	yes	no	0.0	no	no	female	2003.0	other	yes	currently on interferon	0	1.0		no	no									25/03/2020
P_380	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2014.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									02/04/2020
P_383	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2012.0	relapsing_remitting	yes	currently on teriflunomide	0			no	no									09/04/2020
P_385	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	1998.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									14/04/2020
P_393	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	no	0.0	no	no	female	2011.0	relapsing_remitting		currently not using any DMT	0			no	no									17/02/2019
P_401	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes	yes	yes	no	no	yes	yes	no	no	no	no	no	no	0.0	yes	no	female	1999.0	relapsing_remitting	yes	currently not using any DMT	0	1.0	no	yes	yes	no	no	yes	yes	no	no	no	yes	16/12/2013	1.0
P_407	patients	1	not_overweight	no	no	not_suspected	no	no	yes	no											no	never_treated	no	0.0	no	no	female	2017.0	relapsing_remitting	yes		0			no	no
P_41	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	1995.0	relapsing_remitting		currently on rituximab	0			no	no									01/03/2020
P_428	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no	no	no	no	no	no	no	yes	no	no	yes	no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting		currently on teriflunomide	0	1.0		no	no									29/03/2020
P_443	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	1998.0	relapsing_remitting	yes	currently on fingolimod	0			no	no									25/01/2020
P_448	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	1999.0	relapsing_remitting	yes	currently on fingolimod	0		no	yes	yes	no	no	no	no	no	no	no	no	17/04/2020
P_451	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no						yes				yes	no	yes	no	0.0	yes	no	female	2015.0	relapsing_remitting		currently on fingolimod	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	29/03/2020	1.0
P_456	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	1979.0	relapsing_remitting	yes	currently on cladribine	0		no	yes	yes	no	no	no	no	no	no	no	no	05/03/2019	1.0
P_458	patients	1	not_overweight	no	no	suspected	yes	no	no	yes		yes		yes		yes	yes			yes	no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting		currently on another drug not listed	0	1.0		no	no									01/04/2020
P_459	patients	1	not_overweight	no	no	suspected	yes	no	no	no	yes	yes	yes	yes	yes	yes	yes	no		yes	no	no	no	0.0	no	no	female	1982.0	relapsing_remitting		currently not using any DMT	0	1.0		no	no									02/11/2004
P_467	patients	1	not_overweight	no	no	suspected	yes	no	no	yes	yes	no	yes	yes	no	no	yes	no	no	no	no	yes	no	0.0	yes	no	female	2016.0	relapsing_remitting	yes	currently on interferon	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	20/04/2020	1.0
P_469	patients	1	not_overweight	no	no	not_suspected	no	no	no	yes											no	never_treated	no	0.0	no	no	female	2015.0	relapsing_remitting			0			no	no
P_473	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes	no	no	yes	yes	no	no	no	no	no	yes	no	never_treated	no	0.0	no	no	female	2020.0	other			0			no	no
P_475	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes	yes	yes	yes	yes	no	yes	no	yes	yes	no	yes	no	0.0	no	no	female	2009.0	relapsing_remitting	yes	currently on dimethyl fumarate	0	1.0		no	no									13/04/2020
P_476	patients	1	not_overweight	no	no	not_suspected	no	no	no	yes											no	never_treated	no	0.0	no	no	female	2018.0	progressive_MS			0			no	no
P_477	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting		currently on interferon	0			no	no									10/04/2020
P_481	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2017.0	relapsing_remitting	yes	currently on glatiramer	0		no	yes	yes	no	no	no	no	no	yes	no	no	23/04/2020	1.0
P_483	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	yes	yes	no	no	no	yes	no	no	yes	no	yes	no	0.0	no	no	female	2011.0	relapsing_remitting	yes	currently on natalizumab	0			no	no									20/03/2020
P_489	patients	1	not_overweight	no	no	suspected	yes	no	yes	no	no	no	no	no	yes	no	yes	no	no	no	no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on natalizumab	0	1.0		no	no									24/03/2020
P_494	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	yes	yes	no	no	no	yes	no	no	yes	no	yes	no	0.0	no	no	female	1996.0	relapsing_remitting	yes	currently on fingolimod	0	1.0		no	no									23/04/2020
P_495	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									21/04/2020
P_497	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2012.0	relapsing_remitting		currently on ocrelizumab	0		no	yes	yes	no	no	no	no	no	no	no	no	02/12/2019
P_500	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes	yes	yes	yes	yes	yes		yes			yes	no	no	no	0.0	yes	no	female	2000.0	relapsing_remitting	yes	currently not using any DMT	0		no	yes	yes	no	no	no	no	no	no	no	no	27/03/2018	1.0
P_503	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting	yes	currently on cladribine	0			no	no									25/03/2020
P_505	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no	no	no	yes	no	no	no	yes	no	no	yes	no	yes	no	0.0	yes	no	female	2000.0	relapsing_remitting	yes	currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	04/04/2020	1.0
P_51	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	yes	yes	no	no	yes	no	no	no	no	no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting		currently on natalizumab	0	0.0		no	no									13/03/2020
P_515	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2020.0	relapsing_remitting	yes	currently on natalizumab	0			no	no									16/03/2020
P_526	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2014.0	relapsing_remitting	yes	currently on dimethyl fumarate	0		no	yes	yes	no	no	no	no	no	no		no	26/03/2020	1.0
P_529	patients	1	not_overweight	no	no	suspected	yes	no	yes	no		yes	yes	yes					yes		no	yes	no	0.0	yes	no	female	2013.0	relapsing_remitting		currently on another drug not listed	0	0.0		yes	yes									17/03/2020	1.0
P_538	patients	1	not_overweight	no	no	not_suspected	no	no	no	yes											no	yes	no	0.0	no	no	female	2012.0	relapsing_remitting		currently on alemtuzumab	0			no	no									28/02/2018
P_543	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	yes	0.0	no	no	female	2009.0	relapsing_remitting	yes	currently on fingolimod	0			no	no									30/03/2020
P_561	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	yes	yes	no	no	yes	no	no	no	no	no	yes	no	0.0	yes	no	female	2019.0	relapsing_remitting		currently on interferon	0	0.0	no	yes	yes	no	no	no	no	no	no	no	no	14/04/2020	1.0
P_566	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes	yes	yes	no	no	no	no	no	yes	yes	no	no	no	0.0	no	no	female	2009.0	relapsing_remitting		currently not using any DMT	0	1.0		no	no									17/12/2016
P_571	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2017.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									12/04/2020
P_574	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2020.0	relapsing_remitting		currently on glatiramer	0			no	no									01/04/2020
P_579	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	yes	yes	no	no	yes	no	no	no	yes	no	yes	no	0.0	no	no	female	2012.0	relapsing_remitting	yes	currently on ocrelizumab	0	1.0		no	no									15/02/2020
P_581	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2001.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									17/04/2020
P_585	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting		currently on ocrelizumab	0			no	no									11/11/2019
P_588	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2014.0	relapsing_remitting		currently on dimethyl fumarate	0		no	yes	yes	no	no	no	no	no	no	no	yes	16/04/2020
P_59	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2010.0	relapsing_remitting	yes	currently on interferon	0		no	yes	yes	no	no	no	no	yes	no	no	no	13/03/2020	1.0
P_591	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes		yes	yes	yes	yes				yes		no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on dimethyl fumarate	0	1.0		no	no									12/04/2020
P_592	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2014.0	relapsing_remitting		currently on ocrelizumab	0			no	no									24/10/2019
P_597	patients	1	not_overweight	no	no	suspected	yes	no	yes	no	yes	yes	yes	no	yes	no	yes	no	no	no	no	never_treated	no	0.0	no	no	female	2004.0	relapsing_remitting			0			no	no
P_6	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2013.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no
P_601	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2017.0	progressive_MS		currently on ocrelizumab	0		no	yes	yes	no	no	no	no		yes	no	no	23/12/2019
P_607	patients	1	not_overweight	no	no	not_suspected	no	no	no	yes											no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									27/03/2020
P_612	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no			yes								no	never_treated	no	0.0	no	no	female	2019.0	relapsing_remitting	yes		0			no	no
P_63	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	yes	0.0	yes	no	female	2016.0	relapsing_remitting		currently on ocrelizumab	0		no	yes	yes	no	no	no	no	no	no	no	no	19/02/2020	1.0
P_638	patients	1	not_overweight	no	no	suspected	yes	no	no	yes	yes	yes	yes	yes		yes	yes	yes	yes	yes	no	yes	no	0.0	no	no	female	2009.0	relapsing_remitting		currently on another drug not listed	0	1.0		no	no									03/04/2020
P_64	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no						yes	yes			yes	no	yes	no	0.0	yes	no	female	2003.0	relapsing_remitting	yes	currently on teriflunomide	0	1.0	no	yes	yes	no	no	no	no	yes	no	no	no	18/03/2020
P_645	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no	0.0	yes	no	female	2001.0	relapsing_remitting	yes		0		no	yes	yes	no	no	no	no	no	no	no	no		1.0
P_646	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2013.0	relapsing_remitting	yes	currently on fingolimod	0			yes	yes			yes		no	no	no	no	29/03/2020
P_656	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	yes	0.0	yes	no	female	2001.0	relapsing_remitting	yes	currently on ocrelizumab	0		no	yes	yes	no	no	no	no	no	no	no	no	13/03/2020	1.0
P_660	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2018.0	relapsing_remitting	yes	currently on dimethyl fumarate	0		no	yes	yes	no	no	no	no	no	no	no	no	16/04/2020	1.0
P_664	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	yes	no	yes	no	no	no	no	no	no	yes	yes	no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting		currently on cladribine	0			no	no									02/06/2019
P_668	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on cladribine	0			no	no									19/11/2019
P_673	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes		yes		yes							no	yes	no	0.0	yes	no	female	2004.0	relapsing_remitting	yes	currently on ocrelizumab	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	04/02/2020	1.0
P_675	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	yes	0.0	yes	no	female	2004.0	relapsing_remitting		currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	10/11/2019	1.0
P_685	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2014.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									20/04/2020
P_686	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no		female	2014.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no
P_690	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting	yes	currently on teriflunomide	0			no	no									18/04/2020
P_694	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no	0.0	no	no	female	2011.0	relapsing_remitting		currently on alemtuzumab	0			no	no									14/01/2018
P_695	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	1998.0	relapsing_remitting	yes	currently on glatiramer	0			no	no									09/04/2020
P_7	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	no	yes	yes	no	no	yes	yes	no	no	no	yes	no	0.0	yes	no	female	2005.0	relapsing_remitting		currently on dimethyl fumarate	0	1.0	no	yes	yes	no	no	no	no	no	no	no	no	21/03/2020	1.0
P_711	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes		0.0	no	no	female	2019.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no
P_715	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting		currently on another drug not listed	0			no	no									04/04/2020
P_724	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting	yes	currently on fingolimod	0			no	no									09/04/2020
P_725	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									08/04/2020
P_727	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2014.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									17/04/2020
P_737	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting		currently on fingolimod	0			no	no									23/04/2020
P_752	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	yes	no	no	no	yes	no	yes	no	no	no	no	no	yes	no	0.0	no	no	female	2004.0	progressive_MS		currently on fingolimod	0	1.0		no	no									08/04/2020
P_769	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2014.0	other	yes	currently on dimethyl fumarate	0		no	yes	yes	no	no	no	no	no	no	no	no	18/04/2020	1.0
P_77	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	never_treated	no	0.0	no	no	female	2015.0	relapsing_remitting			0			no	no
P_774	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no	yes	no	yes	no	no	yes	yes	no	no	yes	no	yes	no	0.0	no	no	female	2005.0	relapsing_remitting		currently on teriflunomide	0	1.0		no	no									03/04/2020
P_79	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no	no	no	yes	no	no	no	yes	no	yes	yes	no	yes	yes	0.0	no	no	female	2005.0	relapsing_remitting		currently on natalizumab	0	0.0		no	no									21/03/2020
P_791	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2020.0	relapsing_remitting		currently on ocrelizumab	0			no	no									21/12/2019
P_800	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2013.0	relapsing_remitting	yes	currently on interferon	0			no	no									25/04/2020
P_801	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable											yes	no	yes	no	0.0	no	no	female	2001.0	relapsing_remitting		currently on glatiramer	0			no	no									04/04/2020
P_806	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2017.0	relapsing_remitting	yes	currently on interferon	0			no	no									20/04/2020
P_809	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting		currently on interferon	0			no	no									01/04/2020
P_81	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2002.0	relapsing_remitting	yes	currently on glatiramer	0			no	no									14/04/2020
P_817	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2011.0	relapsing_remitting	yes	currently on interferon	0		no	yes	yes	no	no	no	yes	no	no	no	no	17/04/2020
P_829	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2018.0	relapsing_remitting	yes	currently on ocrelizumab	0			no	no									06/03/2020
P_833	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2011.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									02/04/2020
P_837	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									11/04/2020
P_863	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2009.0	relapsing_remitting	yes	currently on natalizumab	0			no	no									21/04/2020
P_869	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting		currently on natalizumab	0			no	no									07/04/2020
P_87	patients	1	not_overweight	no	no	suspected	yes	no	no	no			yes	yes		yes	yes			yes	no	yes	no	0.0	no	no	female	2014.0	relapsing_remitting		currently on another drug not listed	0	1.0		no	no									06/04/2020
P_872	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2012.0	relapsing_remitting		currently on fingolimod	0			no	no									12/04/2020
P_873	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	yes	no	no	no	no	no	no	no	no	no	yes	no	no	no	0.0	no	no	female	2014.0	relapsing_remitting	yes	currently not using any DMT	0			no	no									22/01/2020
P_876	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2004.0	relapsing_remitting		currently on fingolimod	0			no	no									04/05/2020
P_878	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2016.0	relapsing_remitting		currently on another drug not listed	0			no	no									03/04/2020
P_879	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting		currently on another drug not listed	0			no	no
P_88	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable												no	yes	no	0.0	no	no	female	1998.0	other	yes	currently on natalizumab	0			no	no									08/03/2020
P_881	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no	no	no	no	no	no	no	no	no	no	no	no	yes	no	0.0	yes	no	female	2009.0	relapsing_remitting	yes	currently on ocrelizumab	0		no	yes	yes	no	no	no	no	no	no	no	no	04/12/2019	1.0
P_893	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no	no	no	yes	no	no	no	yes	no	no	no	no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting	yes	currently on natalizumab	0			no	no									26/03/2020
P_91	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	no	no	female	2015.0	relapsing_remitting	yes	currently on glatiramer	0			no	no									09/04/2020
P_915	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	1990.0	relapsing_remitting	yes	currently on teriflunomide	0			no	no									06/05/2020
P_926	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2019.0	other	yes	currently on glatiramer	0			no	no									29/04/2020
P_928	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	never_treated	no	0.0	no	no	female	2019.0	other			0			no	no
P_930	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	yes	no	female	2017.0	relapsing_remitting		currently on fingolimod	0			yes	yes									06/05/2020	1.0
P_942	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	no	no	0.0	no	yes	female	2017.0	relapsing_remitting		currently not using any DMT	0			no	no									30/09/2018
P_947	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	never_treated	no	0.0	no	no	female	2010.0	relapsing_remitting			0			no	no
P_951	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no			yes				yes		yes	yes	no	yes	no	0.0	yes	no	female	2001.0	relapsing_remitting		currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	29/04/2020	1.0
P_959	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	1997.0	relapsing_remitting		currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	02/02/2020	1.0
P_960	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2019.0	relapsing_remitting	yes	currently on natalizumab	0			no	no									08/04/2020
P_964	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no
P_965	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no	0.0	no	no	female	2010.0	relapsing_remitting		currently on fingolimod	0			no	no									02/05/2020
P_967	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no	0.0	yes	no	female	2015.0	relapsing_remitting		currently on alemtuzumab	0		no	yes	yes	no	no	no	no	no	no	no	no	03/07/2019	1.0
P_974	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	yes	no	no	yes	no	no	no	yes	no	no	no	no	yes	no	0.0	no	no	female	2008.0	relapsing_remitting	yes	currently on fingolimod	0	1.0		no	no									20/04/2020
P_978	patients	1	not_overweight	no	no	suspected	yes	no	no	no	no	yes	no	no	no	no	no	no	yes	no	no	yes	no	0.0	yes	no	female	2003.0	other		currently on teriflunomide	0		no	yes	yes	no	no	no	no	no	no	no	no	21/04/2020	1.0
P_979	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes	yes	yes	no	yes	yes	yes	no	no	no	no	yes	no	0.0	no	no	female	2014.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									23/04/2020
C_1118	clinicians	1	not_overweight	no	no	suspected	yes	no	yes	yes		yes		yes					yes		no	yes			yes		female		relapsing_remitting	yes	currently on glatiramer	0		no	yes	yes						yes
P_100	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	yes	yes	no	no	no	yes	no	no	no	no	yes	no		no	no	female	2008.0	relapsing_remitting	yes	currently on natalizumab	0			no	no									17/03/2020
P_1003	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	yes	no	yes	no	yes	no	no	yes	yes	no	never_treated	no		no	no	female	2018.0	relapsing_remitting			0			no	no
P_1010	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2010.0	relapsing_remitting	yes	currently on fingolimod	0			no	no
P_1011	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		yes	no	female	2005.0	relapsing_remitting		currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no		1.0
P_1021	patients	1	not_overweight	no	no	suspected	yes	no	yes	no	no	yes	yes	yes	no	yes	yes	no	no	no	no	yes	no		no	no	female	2017.0	relapsing_remitting		currently on dimethyl fumarate	0	1.0		no	no									17/05/2020
P_1027	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	1999.0	relapsing_remitting	yes	currently on glatiramer	0			no	no									15/05/2020
P_1030	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no		no	no	female	2013.0	other			0			no	no
P_1059	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2018.0	relapsing_remitting		currently on teriflunomide	0			no	no									01/05/2020
P_1121	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no		no	no	female	2009.0	relapsing_remitting			0			no	no
P_1122	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no		yes	yes	yes	yes		yes				no	no	no		no	no	female	2015.0	relapsing_remitting		currently not using any DMT	0	1.0		no	no									03/09/2019
P_1134	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	no		yes	no	female	2003.0	relapsing_remitting		currently not using any DMT	0		no	yes	yes	no	no	yes	no	no	no	no	no	23/08/2019
P_1137	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2018.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									10/05/2020
P_1147	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	yes		no	no	female	2013.0	other		currently on rituximab	0			no	no									28/01/2020
P_115	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2013.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									15/04/2020
P_1154	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2001.0	progressive_MS		currently on another drug not listed	0			no	no									05/05/2020
P_1164	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no		yes	yes								no	never_treated	no		yes	no	female	2019.0	relapsing_remitting	yes		0			yes	yes										1.0
P_1170	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2009.0	relapsing_remitting	yes	currently on teriflunomide	0			no	no									02/05/2020
P_1177	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2019.0	relapsing_remitting		currently on glatiramer	0			no	no									04/05/2020
P_1179	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2007.0	relapsing_remitting		currently on fingolimod	0		no	no	no		no	no	no					21/05/2020
P_1180	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		yes	no	female	2002.0	other	yes	currently on dimethyl fumarate	0		no	yes	yes	no	no	no	no	no	no	no	no	29/05/2020	1.0
P_1199	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2015.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									29/04/2020
P_120	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		yes	no	female	2009.0	relapsing_remitting	yes	currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no		1.0
P_1201	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes			yes	no	female	2018.0	relapsing_remitting		currently on cladribine	0			yes	yes									20/05/2020	1.0
P_1206	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2009.0	relapsing_remitting		currently on another drug not listed	0			no	no									28/05/2020
P_121	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	yes		no	no	female	2011.0	progressive_MS		currently on another drug not listed	0			no	no									28/02/2020
P_1215	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2016.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									05/05/2020
P_1218	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2010.0	relapsing_remitting		currently on interferon	0			no	no									09/05/2020
P_1224	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	yes	yes	yes	no	no	no	yes	no	no	yes	no	yes	no		yes	no	female		relapsing_remitting		currently on another drug not listed	0		no	yes	yes	no	yes	no	yes	no	no	no	no	03/06/2020	1.0
P_123	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no		no	no	female	2012.0	other		currently on natalizumab	0			no	no									05/04/2020
P_1231	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2011.0	relapsing_remitting		currently on fingolimod	0			no	no									24/05/2020
P_1239	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no		yes	yes	no	yes	yes	no	yes		no	yes	no		yes	no	female		relapsing_remitting		currently on fingolimod	0		no	yes	yes	no	no	no	no	no	no	no	no	29/01/2013	1.0
P_125	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2009.0	relapsing_remitting		currently on another drug not listed	0			no	no									28/03/2020
P_1252	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no	no	no	yes	no	no	no	yes	no	no	no	no	yes	no		no	no	female		relapsing_remitting	yes	currently on fingolimod	0			no	no
P_1254	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	yes	no	yes	no	no	no	yes	no	no	yes	no	no	no	no		no	no	female		relapsing_remitting		currently not using any DMT	0			no	no
P_1261	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2009.0	relapsing_remitting		currently on another drug not listed	0			no	no									03/03/2020
P_1263	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	1999.0	other	yes	currently on another drug not listed	0			no	no									28/05/2020
P_1271	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no		no	no	female	2017.0	other		currently on dimethyl fumarate	0			no	no									27/05/2018
P_1274	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	yes						yes	yes				no	never_treated	yes		no	no	female		other			0			no	no
P_129	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		yes	no	female	1999.0	relapsing_remitting		currently on fingolimod	0		no	yes	yes	no	no	no	no	no	no	no	no	10/04/2020	1.0
P_130	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		yes	no	female	2012.0	relapsing_remitting		currently on natalizumab	0		no	yes	yes	no	no	no	no	no	no	no	no	13/03/2020	1.0
P_1300	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	no		yes	no	female	1989.0	relapsing_remitting	yes	currently not using any DMT	0		no	yes	yes	no	no	no	no	yes	yes	no	no		1.0
P_1309	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2012.0	relapsing_remitting	yes	currently on another drug not listed	0			no	no									04/07/2020
P_1314	patients	1	not_overweight	no	no	not_suspected	no	no	yes	no											no	yes	no		no	no	female	2018.0	relapsing_remitting		currently on teriflunomide	0			no	no									14/06/2020
P_1315	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2019.0	relapsing_remitting		currently on cladribine	0			no	no									27/05/2020
P_1321	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2018.0	relapsing_remitting	yes	currently on fingolimod	0			no	no									28/05/2020
P_1326	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	yes		no	no	female	2019.0	other		currently on interferon	0			no	no									24/06/2020
P_1329	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2005.0	relapsing_remitting		currently on another drug not listed	0			no	no									28/02/2020
P_1331	patients	1	not_overweight	no	no	not_suspected	no	no	no	yes											no	no	no		yes	no	female	2011.0	relapsing_remitting		currently not using any DMT	0		no	yes	yes	no	no	no	no	no	no	no	no	18/03/2014	1.0
P_1337	patients	1	not_overweight	no	yes	confirmed	yes	no	yes	yes	yes	yes	no	yes	no	no	yes	no	no	no	no	no	no		yes	no	female	2008.0	relapsing_remitting		currently not using any DMT	0	0.0	no	yes	yes	no	no	no	no	no	no	no	no	08/06/2020	1.0
P_1338	patients	1	not_overweight	no	no	suspected	yes	no	yes	no	yes	yes	yes	yes	yes	yes	yes	yes	yes	yes	no	yes	no		no	no	female	2013.0	relapsing_remitting	yes	currently on another drug not listed	0	1.0		no	no									19/07/2020
P_1340	patients	1	not_overweight	no	no	suspected	yes	no	yes	no	no	yes	yes	no	no	yes	yes	no	no	yes	no	yes	no		no	no	female	2018.0	relapsing_remitting		currently on teriflunomide	0	1.0		no	no									17/07/2020
P_1350	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes	no	yes	yes	yes	no	yes	no	no	yes	yes	no	yes	no		no	no	female	2019.0	relapsing_remitting	yes	currently on another drug not listed	0	0.0		no	no									30/07/2020
P_1351	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2016.0	relapsing_remitting		currently on ocrelizumab	0			no	no									14/07/2020
P_1369	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2010.0	relapsing_remitting		currently on ocrelizumab	0			no	no									14/06/2020
P_1379	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	yes		no	no	female	2020.0	other		currently on ocrelizumab	0			no	no									15/07/2020
P_138	patients	1	not_overweight	no	yes	confirmed	yes	no	yes	yes		yes	yes	yes			yes	yes	yes		no	yes	no		no	no	female	2014.0	relapsing_remitting	yes	currently on fingolimod	0	1.0		no	no									11/04/2020
P_1380	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no		no	no	female	2016.0	other			0			no	no
P_143	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	yes		no	no	female	1989.0	relapsing_remitting	yes	currently not using any DMT	0			no	no									04/02/2012
P_146	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	yes	yes	yes	no	no	no	yes	yes	no	no	yes	no	no	no		yes	no	female	1997.0	relapsing_remitting		currently not using any DMT	0	1.0	no	yes	yes	no	no	no	yes	no	no	no	yes	18/03/2020	1.0
P_148	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	yes		no	no	female	2009.0	relapsing_remitting	yes	currently on ocrelizumab	0			no	no									30/01/2020
P_155	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		yes	no	female	2000.0	relapsing_remitting		currently on fingolimod	0		no	yes	yes	no	no	no	no	no	no	yes	no	29/03/2020
P_16	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	no	no		no	no	female	1991.0	relapsing_remitting		currently not using any DMT	0			no	no									15/12/2016
P_167	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2018.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no
P_172	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2009.0	relapsing_remitting		currently on teriflunomide	0			no	no									24/03/2020
P_177	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		yes	no	female	2000.0	relapsing_remitting	yes	currently on dimethyl fumarate	0		no	yes	yes	no	no	no	no	no	no	no	no	21/03/2020	1.0
P_183	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		yes	no	female	1998.0	relapsing_remitting	yes	currently on fingolimod	0		no	yes	yes	no	no	no	no	yes	no	no	no	20/03/2020	1.0
P_186	patients	1	not_overweight	no	no	suspected	yes	no	no	yes	no	yes	yes	no	no	no	yes	no	yes	yes	no	never_treated	no		no	no	female	2016.0	other	yes		0			no	no
P_198	patients	1	not_overweight	yes	no	suspected	yes	no	yes	no	yes	no	yes	yes	no	no	yes	no	yes	yes	no	yes	no		no	no	female	2016.0	relapsing_remitting		currently on fingolimod	1	1.0		no	no
P_201	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2015.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no
P_214	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no		no	no	female	2009.0	relapsing_remitting			0			no	no
P_218	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	never_treated	no		no	no	female	2017.0	relapsing_remitting			0			no	no
P_219	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		yes	no	female	2014.0	other		currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	26/03/2020	1.0
P_221	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2013.0	relapsing_remitting		currently on fingolimod	0			no	no									17/04/2020
P_230	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	yes		no	no	female	2018.0	relapsing_remitting	yes	currently on dimethyl fumarate	0			no	no									23/03/2020
P_233	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2016.0	relapsing_remitting	yes	currently on teriflunomide	0			no	no									21/03/2020
P_247	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no		yes	no	female		progressive_MS		currently on another drug not listed	0		no	yes	yes	yes	yes	no	no	yes	no	no	yes		1.0
P_25	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		yes	no	female	2005.0	relapsing_remitting		currently on alemtuzumab	0		no	yes	yes	no	no	no	no	yes	no	no	no	31/10/2018	1.0
P_259	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no			yes							yes	no	yes	no		no	no	female	2015.0	other	yes	currently on dimethyl fumarate	0			no	no									21/03/2020
P_264	patients	1	not_overweight	no	no	suspected	yes	no	no	yes	yes	yes	yes	yes	yes	yes	yes	no	yes	yes	no	never_treated	no		no	no	female	2004.0	relapsing_remitting	yes		0			no	no
P_265	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2002.0	relapsing_remitting		currently on glatiramer	0			no	no									14/04/2020
P_268	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2018.0	relapsing_remitting		currently on fingolimod	0			no	no									10/04/2020
P_280	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no		yes	no	female		progressive_MS			0			yes	yes										1.0
P_295	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		yes	no	female	2008.0	relapsing_remitting	yes	currently on fingolimod	0		no	yes	yes	no	no	no	no	no	no	no	no	11/04/2020	1.0
P_296	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	yes	yes					yes				yes	no	yes	no		no	no	female	2017.0	relapsing_remitting		currently on another drug not listed	0			no	no									13/04/2020
P_307	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		yes	no	female	2010.0	relapsing_remitting		currently on cladribine	0			yes	yes									19/02/2020	1.0
P_31	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	yes		no	no	female	2015.0	relapsing_remitting	yes	currently on interferon	0			no	no									27/03/2020
P_310	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no		no	no	female	2005.0	relapsing_remitting	yes		0			no	no
P_312	patients	1	not_overweight	no	no	suspected	yes	no	yes	no	no	yes	no	no	yes	no	no	no	no	no	no	yes	yes		no	no	female	2008.0	relapsing_remitting		currently on cladribine	0	1.0		no	no									16/12/2019
P_321	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no		no	no	female	2001.0	other			0			no	no
P_323	patients	1	not_overweight	no	no	not_suspected	yes	no	not_applicable	no	no	no	yes	no	no	no	yes	no	no	yes	no	yes	yes		no	no	female	2010.0	relapsing_remitting		currently on fingolimod	0			no	no
P_327	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2015.0	relapsing_remitting		currently on dimethyl fumarate	0			no	no									13/04/2020
P_328	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2019.0	relapsing_remitting	yes	currently on cladribine	0			no	no									15/11/2019
P_339	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2010.0	relapsing_remitting		currently on cladribine	0			no	no									30/06/2019
P_343	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2012.0	relapsing_remitting	yes	currently on ocrelizumab	0			no	no
P_348	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		yes	no	female	2003.0	relapsing_remitting		currently on interferon	0		no	yes	yes	no	no	no	no	no	no	no	no	17/04/2020	1.0
P_35	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	no	no		yes	no	female	2011.0	relapsing_remitting	yes	currently not using any DMT	0			yes	yes									06/10/2017	1.0
P_355	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		no	no	female	2010.0	relapsing_remitting	yes	currently on natalizumab	0			no	no									08/03/2020
P_360	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable												no	yes	no		no	no	female	2019.0	relapsing_remitting		currently on fingolimod	0			no	no
P_368	patients	1	not_overweight	no	no	not_suspected	no	no	yes	no											no	yes	no		no	no	female	2008.0	relapsing_remitting		currently on fingolimod	0			no	no									14/04/2020
P_374	patients	1	not_overweight	no	no	suspected	yes	no	yes	no	no	yes	no	no	yes	yes	yes	no	no	yes	no	yes	no		no	no	female	2016.0	other		currently on glatiramer	0	1.0		no	no									16/04/2020
P_375	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no		no	no	female	2008.0	other	yes		0			no	no
P_377	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes	yes	yes	yes	yes	yes	yes	no	yes	no	no	no	yes	no		yes	no	female	2016.0	relapsing_remitting		currently on fingolimod	0	1.0	no	yes	yes	no	no	no	no	yes	no		no	14/04/2020	1.0
P_396	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	never_treated	no		no	no	female	2015.0	relapsing_remitting			0			no	no
P_398	patients	1	not_overweight	no	no	suspected	yes	no	not_applicable	no	no	yes	yes	yes	yes	no	yes	no	no	yes	no	yes	no		yes	no	female		relapsing_remitting		currently on ocrelizumab	0	0.0		yes	yes									16/11/2019	1.0
P_409	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2013.0	relapsing_remitting		currently on glatiramer	0			no	no
P_412	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	never_treated	no		no	no	female	2009.0	relapsing_remitting	yes		0			no	no
P_419	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2019.0	relapsing_remitting	yes	currently on natalizumab	0			no	no
P_421	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	yes	no		no	no	female	2013.0	relapsing_remitting	yes	currently on fingolimod	0			no	no
P_422	patients	1	not_overweight	no	no	suspected	yes	no	yes	yes	no	yes	yes	no	yes	no	yes	no	no	no	no	yes	no		no	no	female	2005.0	relapsing_remitting	yes	currently on fingolimod	0	0.0		no	no									21/04/2020
P_426	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	yes											no	yes	no		yes	no	female	2010.0	relapsing_remitting	yes	currently on another drug not listed	0		no	yes	yes	no	no	no	no	no	no	no	no	29/03/2020	1.0
P_430	patients	1	not_overweight	no	no	not_suspected	no	no	no	no											no	yes	no		no	no	female	2000.0	relapsing_remitting	yes	currently on interferon	0			no	no									09/04/2020
P_437	patients	1	not_overweight	no	no	not_suspected	no	no	not_applicable	no											no	never_treated	no		no	no	female	2002.0	relapsing_remitting			0			no	no

Only the first 500 rows are shown. Click here to download the complete file.